Skip to main content

Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial

Osteoporosis International volume 27, pages 1209–1216 (2016)Cite this article

Abstract

Summary

Calcium supplements have been associated with increased cardiovascular risk, but the mechanism is unknown. We investigated the effects of calcium supplements on the propensity of serum to calcify, based on the transition time of primary to secondary calciprotein particles (T50). Changes in serum calcium were related to changes in T50.

Introduction

Calcium supplements have been associated with increased cardiovascular risk; however, it is unknown whether this is related to an increase in vascular calcification.

Methods

We investigated the acute and 3-month effects of calcium supplements on the propensity of serum to calcify, based on the transition time of primary to secondary calciprotein particles (T50), and on three possible regulators of calcification: fetuin-A, pyrophosphate and fibroblast growth factor-23 (FGF23). We randomized 41 postmenopausal women to 1 g/day of calcium as carbonate, or to a placebo containing no calcium. Measurements were performed at baseline and then 4 and 8 h after their first dose, and after 3 months of supplementation. Fetuin-A, pyrophosphate and FGF23 were measured in the first 10 participants allocated to calcium carbonate and placebo who completed the study.

Results

T50 declined in both groups, the changes tending to be greater in the calcium group. Pyrophosphate declined from baseline in the placebo group at 4 h and was different from the calcium group at this time point (p = 0.04). There were no other significant between-groups differences. The changes in serum total calcium from baseline were significantly related to changes in T50 at 4 h (r = −0.32, p = 0.05) and 8 h (r = −0.39, p = 0.01), to fetuin-A at 3 months (r = 0.57, p = 0.01) and to pyrophosphate at 4 h (r = 0.61, p = 0.02).

Conclusions

These correlative findings suggest that serum calcium concentrations modulate the propensity of serum to calcify (T50), and possibly produce counter-regulatory changes in pyrophosphate and fetuin-A. This provides a possible mechanism by which calcium supplements might influence vascular calcification.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Bolland MJ, Grey A, Avenell A et al (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bolland MJ, Avenell A, Baron JA et al (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:c3691

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mao P-J, Zhang C, Tang L et al (2013) Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol 169:106–111

    Article  PubMed  Google Scholar 

  4. Lewis JR, Radavelli-Bagatini S, Rejnmark L et al (2015) The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. J Bone Miner Res 30:165–175

    CAS  Article  PubMed  Google Scholar 

  5. Bolland MJ, Grey A, Avenell A et al (2015) Calcium supplements increase risk of myocardial infarction. J Bone Miner Res 30:389–390

    CAS  Article  PubMed  Google Scholar 

  6. Heaney RP, Dowell MS, Bierman J et al (2001) Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 20:239–246

    CAS  Article  PubMed  Google Scholar 

  7. Bristow SM, Gamble GD, Stewart A et al (2014) Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women. Br J Nutr 112:1611–1620

    CAS  Article  PubMed  Google Scholar 

  8. Rubin MR, Rundek T, McMahon DJ et al (2007) Carotid artery plaque thickness is associated with increased serum calcium levels: the northern Manhattan study. Atherosclerosis 194:426–432

    CAS  Article  PubMed  Google Scholar 

  9. Kwak SM, Kim JS, Choi Y et al (2014) Dietary intake of calcium and phosphorus and serum concentration in relation to the risk of coronary artery calcification in asymptomatic adults. Arterioscler Thromb Vasc Biol 34:1763–1769

    CAS  Article  PubMed  Google Scholar 

  10. Shin S, Kim KJ, Chang HJ et al (2012) Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. Eur Heart J 33:2873–2881

    CAS  Article  PubMed  Google Scholar 

  11. Bolland MJ, Wang TK, van Pelt NC et al (2010) Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction. J Bone Miner Res 25:505–512

    CAS  Article  PubMed  Google Scholar 

  12. Russo D, Miranda I, Ruocco C et al (2007) The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 72:1255–1261

    CAS  Article  PubMed  Google Scholar 

  13. Li S, Na L, Li Y et al (2013) Long-term calcium supplementation may have adverse effects on serum cholesterol and carotid intima-media thickness in postmenopausal women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 98:1353–1359

    CAS  Article  PubMed  Google Scholar 

  14. Heiss A, DuChesne A, Denecke B et al (2003) Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278:13333–13341

    CAS  Article  PubMed  Google Scholar 

  15. Meyer JL (1984) Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 231:1–8

    CAS  Article  PubMed  Google Scholar 

  16. Moe OW, Kuro-o M (2014) Fibroblast growth factor 23 and uremic vascular calcification: is it time to escalate from biomarker status to pathogenic agent? Kidney Int 85:1022–1023

    CAS  Article  PubMed  Google Scholar 

  17. Reid IR, Bolland MJ, Grey A (2010) Does calcium supplementation increase cardiovascular risk? Clin Endocrinol 73:689–695

    CAS  Article  Google Scholar 

  18. Pasch A, Farese S, Graber S et al (2012) Nanoparticle-based test measures overall propensity for calcification in serum. J Am Soc Nephrol 23:1744–1752

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. Keyzer CA, de Borst MH, van den Berg E et al (2015) Calcification propensity and survival among renal transplant recipients. J Am Soc Nephrol

  20. Smith ER, Ford ML, Tomlinson LA et al (2014) Serum calcification propensity predicts all-cause mortality in pre-dialysis CKD. J Am Soc Nephrol 25:339–348

    CAS  Article  PubMed  Google Scholar 

  21. Lomashvili KA, Khawandi W, O'Neill WC (2005) Reduced plasma pyrophosphate levels in hemodialysis patients. J Am Soc Nephrol 16:2495–2500

    CAS  Article  PubMed  Google Scholar 

  22. Schaible J, Wigger M, Staude H et al (2012) Serum fetuin-A and vitamin D in children with mild-to-severe chronic kidney disease: a cross-sectional study. Nephrol Dial Transplant 27:1107–1113

    CAS  Article  PubMed  Google Scholar 

  23. Liang J, Wang Z, Liu G et al (2014) Association of dialysate calcium concentration with fetuin a level and carotid intima-media thickness in peritoneal dialysis patients. Ren Fail 36:65–68

    CAS  Article  PubMed  Google Scholar 

  24. Mehrotra R, Westenfeld R, Christenson P et al (2005) Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int 67:1070–1077

    CAS  Article  PubMed  Google Scholar 

  25. Hamano T, Matsui I, Mikami S et al (2010) Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21:1998–2007

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  26. O'Neill WC, Sigrist MK, McIntyre CW (2010) Plasma pyrophosphate and vascular calcification in chronic kidney disease. Nephrol Dial Transplant 25:187–191

    Article  PubMed  Google Scholar 

  27. Wesseling-Perry K, Wang H, Elashoff R et al (2014) Lack of FGF23 response to acute changes in serum calcium and PTH in humans. J Clin Endocrinol Metab 99:E1951–E1956

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  28. Rodriguez-Ortiz ME, Lopez I, Munoz-Castaneda JR et al (2012) Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 23:1190–1197

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. Kobayashi K, Imanishi Y, Miyauchi A et al (2006) Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol 154:93–99

    CAS  Article  PubMed  Google Scholar 

  30. Imanishi Y, Inaba M, Nakatsuka K et al (2004) FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 65:1943–1946

    CAS  Article  PubMed  Google Scholar 

  31. Nishida Y, Taketani Y, Yamanaka-Okumura H et al (2006) Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70:2141–2147

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. University of Auckland, Auckland, New Zealand

    S. M. Bristow, G. D. Gamble, A. Stewart, A. M. Horne & I. R. Reid

  2. Department of Clinical Chemistry, University Hospital Bern, Inselspital, Bern, Switzerland

    A. Pasch

  3. Renal Division, School of Medicine, Emory University, Atlanta, GA, USA

    W. C. O’Neill

  4. Department of Endocrinology, Auckland District Health Board, Auckland, New Zealand

    I. R. Reid

  5. Faculty of Medical and Health Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand

    I. R. Reid

Authors
  1. S. M. Bristow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. D. Gamble
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Pasch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. C. O’Neill
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. M. Horne
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. R. Reid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. R. Reid.

Ethics declarations

The study was approved by a government ethics committee and all participants gave informed consent.

Conflicts of interest

Andreas Pasch is a co-founder of Calciscon AG, Bern, Switzerland. Sarah Bristow, Greg Gamble, W. Charles O’Neill, Angela Stewart, Anne Horne and Ian Reid have no disclosures to declare.

Additional information

This paper was supported by the Health Research Council of New Zealand.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOCX 156 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bristow, S.M., Gamble, G.D., Pasch, A. et al. Acute and 3-month effects of calcium carbonate on the calcification propensity of serum and regulators of vascular calcification: secondary analysis of a randomized controlled trial. Osteoporos Int 27, 1209–1216 (2016). https://doi.org/10.1007/s00198-015-3372-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-015-3372-y

Keywords

  • Calcification
  • Calcium
  • Cardiovascular